Bioqual (OTCMKTS:BIOQ) Shares Down 0.7% - Here's Why

Bioqual, Inc. (OTCMKTS:BIOQ - Get Free Report) fell 0.7% during trading on Tuesday . The company traded as low as $67.00 and last traded at $67.00. 1 shares were traded during mid-day trading, a decline of 100% from the average session volume of 344 shares. The stock had previously closed at $67.50.

Bioqual Stock Down 0.7 %

The firm has a fifty day moving average price of $68.54 and a two-hundred day moving average price of $71.12. The stock has a market capitalization of $60.30 million, a P/E ratio of 62.62 and a beta of -0.31.

Bioqual (OTCMKTS:BIOQ - Get Free Report) last released its quarterly earnings data on Tuesday, October 22nd. The company reported ($0.76) earnings per share for the quarter. The firm had revenue of $11.77 million for the quarter. Bioqual had a net margin of 0.81% and a return on equity of 1.23%.

Bioqual Dividend Announcement

The firm also recently disclosed an annual dividend, which was paid on Monday, October 28th. Investors of record on Monday, October 7th were given a $0.50 dividend. The ex-dividend date was Monday, October 7th. This represents a yield of 0.74%. Bioqual's dividend payout ratio (DPR) is presently 46.73%.

Bioqual Company Profile

Bioqual, Inc provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States. The company provides research services in the areas of COVID-19, AIDS, influenza, RSV infection, and flavivirus infections, including zika, dengue, malaria, hepatitis, and cancer.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.